Abstract
A composition for oromucosal delivery of at least one active ingredient, more particularly a lipid nano-microdelivery system comprising a nicotine component and/or a flavour component, wherein the nicotine component may be delivered to the oral cavity via absorption through the mucosal membranes thereof and/or wherein the flavour component may be delivered to the oral mucosa by controlled release.
Original language | English |
---|---|
IPC | A61K31/465 |
Patent number | WO2014135630 |
Filing date | 12/09/2014 |
Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
Priority date | 07/03/2013 |
Priority number | EP20130158191 |
Publication status | Published - 2014 |